Stay updated with breaking news from Externalized Immune System. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Former Generate Biomedicines, Amgen and Novartis senior leader Mike Nohaile joins Prellis as CEOSAN FRANCISCO--(BUSINESS WIRE)--Prellis Biologics, Inc (Prellis Bio), a biotherapeutics company, today appointed Michael Nohaile, PhD as its new CEO and announced it has raised a $35 million Series C funding round, co-led...
Prellis Biologics, a company developing the tools to create 3D printed organs, announced a $14.5 million Series B round on Wednesday. Prellis has spent years developing tissue engineering capacity, but has focused recently on developing one type of structure in particular. Up until this point, Prellis has focused on 3D printing vascular scaffolds that would […]
San Francisco, CA (PRWEB) December 15, 2021 -- Prellis Biologics announced today that it has closed a $14.5 million Series B financing round, led by Celesta